Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand

Executive Summary

US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.

Advertisement

Related Content

States With Age Restriction On OTC DXM Sales Number 17 – And Counting
States With Age Restriction On OTC DXM Sales Number 17 – And Counting
Perrigo Recalls Tamper-Resistant PSE Product Due To Contamination
Perrigo Recalls Tamper-Resistant PSE Product Due To Contamination
Sunscreen Firm Warned, Natural Balms Among Recent Recalls: Consumer Health News
Industry Roundup: Warning Letters, DXM Bill, Nutrition Label Update
DXM Sales Age Restriction Reaches Florida; CHPA Navigates PSE Road
To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
FDA Panel Says Leave DXM Unscheduled For Now, Urges Congressional Action
Combat Meth Act Compliance Can Trip Up Drug Retailers

Topics

Advertisement
UsernamePublicRestriction

Register

PS120189

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel